Evidence map›Paper›PMID 26236292›Full record

ArticleFrontiers in microbiology2015

The impact of absorbed photons on antimicrobial photodynamic efficacy.

Fabian Cieplik, Andreas Pummer, Johannes Regensburger, Karl-Anton Hiller, Andreas Späth, Laura Tabenski, Wolfgang Buchalla, Tim Maisch

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Yonago acta medica · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Membrane damage as mechanism of photodynamic inactivation using Methylene blue and TMPyP in Escherichia coli and Staphylococcus aureus.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. What anMicroorganisms · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Anti-Adhesive Effect of Curcumin onFrontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fabian CieplikDepartment of Conservative Dentistry and Periodontology, University Medical Center Regensburg Regensburg, Germany.
Andreas PummerDepartment of Conservative Dentistry and Periodontology, University Medical Center Regensburg Regensburg, Germany.
Johannes RegensburgerDepartment of Dermatology, University Medical Center Regensburg Regensburg, Germany.
Karl-Anton HillerDepartment of Conservative Dentistry and Periodontology, University Medical Center Regensburg Regensburg, Germany.
Andreas SpäthDepartment of Organic Chemistry, University of Regensburg Regensburg, Germany.
Laura TabenskiDepartment of Conservative Dentistry and Periodontology, University Medical Center Regensburg Regensburg, Germany.
Wolfgang BuchallaDepartment of Conservative Dentistry and Periodontology, University Medical Center Regensburg Regensburg, Germany.
Tim MaischDepartment of Dermatology, University Medical Center Regensburg Regensburg, Germany.
University of Regensburg · DEUniversity Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to increasing resistance of pathogens toward standard antimicrobial procedures, alternative approaches that are capable of inactivating pathogens are necessary in support of regular modalities. In this instance, the photodynamic inactivation of bacteria (PIB) may be a promising alternative. For clinical application of PIB it is essential to ensure appropriate comparison of given photosensitizer (PS)-light source systems, which is complicated by distinct absorption and emission characteristics of given PS and their corresponding light sources, respectively. Consequently, in the present study two strategies for adjustment of irradiation parameters were evaluated: (i) matching energy doses applied by respective light sources (common practice) and (ii) by development and application of a formula for adjusting the numbers of photons absorbed by PS upon irradiation by their corresponding light sources. Since according to the photodynamic principle one PS molecule is excited by the absorption of one photon, this formula allows comparison of photodynamic efficacy of distinct PS per excited molecule. In light of this, the antimicrobial photodynamic efficacy of recently developed PS SAPYR was compared to that of clinical standard PS Methylene Blue (MB) regarding inactivation of monospecies biofilms formed by Enterococcus faecalis and Actinomyces naeslundii whereby evaluating both adjustment strategies. PIB with SAPYR exhibited CFU-reductions of 5.1 log10 and 6.5 log10 against E. faecalis and A. naeslundii, respectively, which is declared as a disinfectant efficacy. In contrast, the effect of PIB with MB was smaller when the applied energy dose was adjusted compared to SAPYR (CFU-reductions of 3.4 log10 and 4.2 log10 against E. faecalis and A. naeslundii), or there was even no effect at all when the number of absorbed photons was adjusted compared to SAPYR. Since adjusting the numbers of absorbed photons is the more precise and adequate method from a photophysical point of view, this strategy should be considered in further studies when antimicrobial efficacy rates of distinct PS-light source systems are compared.

Indexed as

absorbed photonsantimicrobial resistancebiofilmMethylene BluephotodynamicSAPYR

Identifiers

PMID26236292
PMCPMC4502582
OpenAlexW1521779473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.